Skin Irritation Unknown Status Phase 1 Trials for Sodium lauryl sulfate (DB00815)

Also known as: Skin irritants / Itch / Irritation skin

IndicationStatusPhase
DBCOND0062614 (Skin Irritation)Unknown Status1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01821274A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test DesignTreatment